Skip to search formSkip to main contentSkip to account menu

Atovaquone

Known as: 3-(4-(4-chlorophenyl)cyclohexyl)-4-hydroxy-naphthalene-1,2-dione, 2-(trans-4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone, 2-(4-(4'-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone 
A synthetic hydroxynaphthoquinone with antiprotozoal activity. Atovoquone blocks the mitochondrial electron transport at complex III of the… 
National Institutes of Health

Related topics

Related topics

30 relations

Narrower (6)

566C566C80Atovaquone / ProguanilBW-566C

Broader (6)

Anti-Infective AgentsAntifungal AgentsAntimalarialsAntiparasitic Agents
Antiprotozoal AgentsAtovaquone 150 MG/ML Oral Suspension [Mepron]Atovaquone 250 MG / proguanil hydrochloride 100 MG Oral TabletAtovaquone 62.5 MG / proguanil hydrochloride 25 MG Oral Tablet [Malarone]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
HPLC METHOD DEVELOPMENT FOR SIMULTANEOUS ESTIMATION OF ATOVAQUONE AND PROGUANIL IN TABLET DOSAGE FORM Research Article
This research article describes simple, accurate and precise, RP-HPLC procedure for the estimation of Proguanil and Atovaquone in… 
2012
2012
QSAR Studies of Potent Inhibitors of Malaria Parasite Dihydroorate Dehydrogenase By Comparative Analysis
Three-dimensional quantitative structure–activity relationship (3D-QSAR) analyses were carried out on derivatives as Dihydroorate… 
2003
2003
LINEE GUIDA PER LA PROFILASSI ANTIMALARICA
These guidelines are designed to provide health care workers who advise travellers with the best available evidence on malaria… 
2003
2003
[Imported malaria in 2000 in 2 northern Paris hospitals].
The number of travellers in malaria striken areas increases each year (2). The risk of infection is high in Sub-Saharan Africa… 
2000
2000
FOR PNEUMOCYSTIS CARINII PNEUMONIA IN PATIENTS WITH HIV INFECTION ATOVAQUONE COMPARED WITH DAPSONE FOR THE PREVENTION OF PNEUMOCYSTIS CARINII PNEUMONIA IN PATIENTS WITH HIV INFECTION WHO CANNOT…
A BSTRACT Background Although trimethoprim–sulfamethoxazole is the drug of choice for the prevention of Pneumocystis carinii… 
1997
1997
TOXOPLASMOSIS IN IMMUNOCOMPROMISED PATIENTS
Recent studies have defined the incidence of severe toxoplasmosis in heart transplant and AIDS patients and the indications for… 
1995
1995
Antipneumocystis activity of 17C91, a prodrug of atovaquone
The prophylactic efficacy of 17C91, a carbamate prodrug of atovaquone (ATQ), was investigated in a severe combined… 
1995
1995
Atovaquone (Mepron) suspension approved by FDA. Food and Drug Administration.
The newly approved use of an Atovaquone (Mepron) suspension for treating mild to moderate Pneumocystis carinii (PCP) in… 
1995
1995
Atovaquone (Mepron) Suspension Approved by FDA
The FDA has recently approved the use of atovaquone (Mepron) suspension for the treatment of mild to moderate Pneumocystis… 
1995
1995
In-vitro activity of terbinafine, atovaquone and co-trimoxazole against Pneumocystis carinii.